Cargando…
Treatment outcome of high-dose image-guided intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer at a single institute in Japan
BACKGROUND: Several studies have confirmed the advantages of delivering high doses of external beam radiotherapy to achieve optimal tumor-control outcomes in patients with localized prostate cancer. We evaluated the medium-term treatment outcome after high-dose, image-guided intensity-modulated radi...
Autores principales: | Takeda, Ken, Takai, Yoshihiro, Narazaki, Kakutaro, Mitsuya, Masatoshi, Umezawa, Rei, Kadoya, Noriyuki, Fujita, Yukio, Sugawara, Toshiyuki, Kubozono, Masaki, Shimizu, Eiji, Abe, Keiko, Shirata, Yuko, Ishikawa, Yohjiro, Yamamoto, Takaya, Kozumi, Maiko, Dobashi, Suguru, Matsushita, Haruo, Chida, Koichi, Ishidoya, Shigeto, Arai, Yoichi, Jingu, Keiichi, Yamada, Shogo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493327/ https://www.ncbi.nlm.nih.gov/pubmed/22770471 http://dx.doi.org/10.1186/1748-717X-7-105 |
Ejemplares similares
-
Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors
por: Yamamoto, Takaya, et al.
Publicado: (2014) -
Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
por: Umezawa, Rei, et al.
Publicado: (2011) -
Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study
por: Takahashi, Noriyoshi, et al.
Publicado: (2016) -
Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy
por: Yamamoto, Takaya, et al.
Publicado: (2015) -
Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer
por: Takeda, Kazuya, et al.
Publicado: (2023)